FIELD: medicine.
SUBSTANCE: improving the psychomotor action in individuals suffering from mild and moderate anxiodepressive disorders is ensured by prescribing anxiolytic afobazol in a daily dose of 30-60 mg divided in three times throughout the day. The therapeutic course makes 14 days.
EFFECT: invention provides higher speed of hand-eye reactions accompanied by reduced responsiveness to a visual signal.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF PATIENTS WITH LICHEN PLANUS | 2016 |
|
RU2629601C1 |
| METHOD FOR TREATMENT OF PATIENTS WITH ROSACEA | 2022 |
|
RU2793793C1 |
| METHOD OF TREATING CHRONIC DERMATOSES | 2018 |
|
RU2709534C1 |
| METHOD FOR DETECTION OF DEFATIGATION IN OPERATORS | 2011 |
|
RU2467683C1 |
| METHOD OF TREATING FOURTH-DEGREE COXARTHROSIS | 2013 |
|
RU2546295C1 |
| METHOD FOR PROGRAMMED IRRIGATION-ASPIRATION SANATION IN PURULO-NECROTIC COMPLICATIONS OF DIABETIC FOOT INFECTIONS | 2013 |
|
RU2539165C1 |
| METHOD OF TREATMENT OF ISCHEMIC STROKE IN ACUITY | 2017 |
|
RU2669025C1 |
| METHOD OF INTEGRATED MEDICAL-PSYCHOLOGICAL REHABILITATION OF PATIENTS IN LATE RECOVERY PERIOD AFTER ACUTE CEREBRAL CIRCULATION DISORDER | 2019 |
|
RU2724284C1 |
| METHOD OF TREATMENT OF ISCHEMIC STROKE IN ACUITY | 2017 |
|
RU2683038C2 |
| METHOD FOR PREDICTION OF STAGE OF MULTIPLE SCLEROSIS TAKING INTO ACCOUNT VALUES OF IMMUNOLOGICAL STATUS | 2013 |
|
RU2528882C1 |
